Imidazoquinolines as dual lipid kinase and mtor inhibitors

Details Imidazoquinolines as dual lipid kinase and mtor inhibitors Imidazoquinolines as dual lipid kinase and mtor inhibitors

A - Human Necessities

61

K

A61K 31/4745 (2006.01) A61P 7/00 (2006.01) A61P 9/00 (2006.01) A61P 11/00 (2006.01) A61P 25/00 (2006.01) A61P 27/02 (2006.01) A61P 31/04 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2676786

The invention relates to the use of compounds of formula: (I) in the treatment of mammalian target of rapamycin (mTOR) kinase dependent diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases.

L'invention concerne l'utilisation de composés de la formule : (I) dans le traitement de maladies dépendant de la kinase de la cible de la rapamycine chez les mammifères (mTOR), des procédés d'utilisation desdits composés dans le traitement desdites maladies chez un animal à sang chaud, spécialement un être humain, des préparations pharmaceutiques comportant lesdits composés pour le traitement desdites maladies et lesdits composés pour une utilisation dans le traitement desdites maladies.

Affiliated with

Also associated with

Rating

Imidazoquinolines as dual lipid kinase and mtor inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazoquinolines as dual lipid kinase and mtor inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoquinolines as dual lipid kinase and mtor inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1576221